![]() |
市场调查报告书
商品编码
1362390
眼底相机市场规模和预测、全球和地区份额、趋势和成长机会分析报告范围:按类型、便携性、应用程式、最终用户和地理位置Fundus Camera Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type, Portability, Application, End User, and Geography |
眼底相机市场预计将从2022年的7.0801亿美元成长到2030年的12.9825亿美元;预计2022年至2030年复合年增长率为7.9%。糖尿病视网膜病变筛检程序的增加和创新产品的推出是推动眼底相机市场成长的几个因素。
眼底摄影有助于检测和筛检可治疗和可预防失明的各种原因,特别是 DR、老年黄斑部病变、青光眼和早产儿视网膜病变。根据疾病管制与预防中心的数据,老年性黄斑部病变 (AMD) 是 65 岁及以上美国人失明和视力丧失的主要原因。据 CDC 称,美国老年人口预计将从 2015 年的 4800 万增加到 2050 年的 8800 万,几乎翻倍。美国有近 2000 万成年人面临某种形式的年龄相关性黄斑部病变。
DR 是糖尿病患者常见的复杂情况。根据国际糖尿病联盟 (IDF) 的数据,2021 年约有 5.37 亿成年人(20-79 岁)患有糖尿病。同一消息来源还报告称,糖尿病患者总数估计将增至 6.43 亿到2030 年。此外,美国小儿眼科和斜视协会(AAPOS) 的研究(于2023 年4 月更新)分析称,在美国,每年约有390 万婴儿出生时患有早产儿视网膜病变。此外,据估计,其中约有 14,000 人受到这种情况的影响,其中 90% 的人仅患有轻度疾病,近 1,100-1,500 人病情严重,需要接受治疗。因此,人口中早产儿视网膜病变、DR和老年黄斑部病变的盛行率上升有助于美国眼底相机市场的成长。
此外,用于治疗黄斑水肿的产品在中国的快速批准进一步加速了眼底相机在亚太地区的采用。根据记录,拜耳宣布批准 Eylea 用于治疗视力障碍患者的黄斑水肿。此次批准是Eylea获得中国监管机构批准的第一个产品适应症,也是Regeneron销售的眼用注射药物的首个产品适应症。此核准用于治疗湿性老年黄斑部病变、视网膜静脉阻塞和糖尿病黄斑水肿等疾病。上述因素将在 2022-2030 年预测期间加速眼底相机市场的采用。
市场机会
使用智慧型手机进行眼底检查
高解析度智慧型手机相机的发展可以彻底改变传统的眼底摄影。例如,眼科医生正在探索用智慧型手机取代双眼间接检眼镜的可能性,从而在眼底镜检查领域带来创新。智慧型手机辅助眼底镜检查是一种高科技、低成本的成像替代方案,透过设备的便携性使用户受益。智慧型手机相机配备光源。此外,该设备还可以随时存取安全网路以进行资料传输。
与扩增实境整合的行动装置创造了全新的眼底检查体验。眼底相机市场的公司正在与医疗科技企业合作,开发基于应用程式的眼底镜检查,以简化眼科检查流程。例如,Ullman Indirect App允许用户控制相应智慧型手机相机的功能。透过其先进的功能,该应用程式可以手动对焦相机并保存眼睛的焦点,手动控制相机曝光,调节手电筒强度,旋转影像和影片以记录正确方向的发现,以及无需萤幕截图即可导出高品质影像。
基于类型的见解
根据类型,眼底相机市场分为散瞳眼底相机、免散瞳眼底相机、混合眼底相机和ROP眼底相机。免散瞳眼底相机细分市场在2022年占据最大的市场份额。散瞳眼底相机在眼底相机市场中占据了显着的复合年增长率。免散瞳眼底相机专注于视盘、视网膜和晶状体的高清影像捕获,这可以透过仪器的低倍显微镜来实现,而无需增加瞳孔尺寸。与散瞳眼底相机相比,免散瞳眼底相机最显着的优势之一是其革命性的升级,无需散瞳即可拍摄更大更清晰的影像。此外,免散瞳眼底相机对患者友好,消除了眨眼后30分钟的扩瞳和眼睛调节等待时间,有助于眼科医生提高诊断效率。
CX-1 混合数位散瞳/免散瞳 (MYD/NM) 视网膜相机是佳能第一款使用眼底自发萤光 (FAF) 摄影的混合相机和免散瞳相机。 CX-1 提供五种拍照模式:彩色、无红色、钴、萤光素血管摄影 (FA) 和眼底自发萤光 (FAF)。
同样,独立散瞳眼底相机原型也已成功开发,原型相机能够以傻瓜式方式操作。此外,散瞳眼底相机提供自动影像聚焦和曝光,眼底照片的影像品质可与现有商用相机相媲美。例如,散瞳眼底相机的采用对于筛检患有糖尿病视网膜病变和老年黄斑部病变的患者来说意义重大,这些患者很容易从眼底影像中识别出来。
2020 年 10 月,Volk Optical 宣布推出“The Volk VistaView”,这是一款用于眼底成像的新型便携式散瞳视网膜相机。新推出的产品透过直觉的数位平台提供高解析度、全玻璃、双非球面光学元件,可撷取清晰的宽视野影像并在装置上管理患者资料。
基于可移植性的见解
基于便携性,全球眼底相机市场分为手持式和桌上型。桌面细分市场在 2022 年占据更大的市场份额。手持细分市场预计在 2020-2030 年期间将以更高的复合年增长率成长。眼底照相有助于检测和筛检可治疗和可预防失明的各种原因,特别是糖尿病性视网膜病变 (DR)、老年黄斑部病变、青光眼和早产儿视网膜病变。手持相机是一种较小的便携式成像设备。该工具由电池供电,不需要支架或桌子即可操作。手持相机往往比桌上型相机便宜。便携性和低成本有助于视网膜成像设备的高可用性。手持相机用于家庭、行动诊所和健康展览会。
现代手持式眼底相机与自主人工智慧系统相结合,由于检测灵敏度和影像品质高,非常适合无散瞳的 DR 筛检。然而,这些相机的特异性需要透过更好的资料建模来提高。美国俄亥俄州 Mentor 生产的 Volk iNview 眼底相机可透过应用程式与 iPhone 6s/6/5s 或 iPod Touch (Gen 6) 连接。 Volk Pictor Plus 是一款免散瞳眼底相机,具有后部(视网膜)和前部成像模组;该相机使用专有镜头,并且可以下载应用程式来拍摄眼底图像。手持式摄影机现已成为一种新的低成本 DR 筛检工具,可供无法获得眼科护理的患者方便地使用。
基于应用程式的见解
从应用来看,眼底相机市场分为糖尿病性视网膜病变、老年黄斑部病变、视网膜血管疾病等。到 2022 年,糖尿病视网膜病变细分市场将占据最大的眼底相机市场。糖尿病 (DM) 被认为是一种流行病。据糖尿病研究所称,目前美国有 3730 万人患有糖尿病。
糖尿病视网膜病变 (DR) 是糖尿病最重要的长期併发症之一,也是 20-74 岁族群失明的主要原因。截至 2020 年,美国患有糖尿病视网膜病变的成年人人数约为 800 万人;预计到2050年将达到1600万。它可以是增殖性(正在生长)或非增殖性(不生长),指的是视网膜中异常血管的发育。非增殖性视网膜病变较为常见,可能不需要治疗。当增殖性视网膜病变中的正常血管被切断时,异常血管就开始形成。增殖性视网膜病变可能导致视力丧失。应透过常规眼科检查监测视网膜病变从非增殖期到增殖期的病程。眼底摄影对于管理和记录糖尿病眼疾至关重要。传统上,眼底摄影是使用底片进行的,但最近,数位眼底摄影获得了巨大的关注。数位影像可以轻鬆、即时地查看影像、直接放大影像并且能够轻鬆验证影像。
美国食品药物管理局、美国小儿眼科和斜视协会、沙乌地阿拉伯食品药物管理局 (SFDA) 和美国医院协会 (AHA) 是准备眼底相机市场报告时参考的主要和次要来源。
The fundus camera market is expected to grow from US$ 708.01 million in 2022 to US$ 1,298.25 million by 2030; it is expected to grow at a CAGR of 7.9% from 2022 to 2030. increase in diabetic retinopathy screening procedures and launches of innovative products are a few factors driving the fundus camera market growth.
Fundus photography is instrumental in the detection and screening of various causes of treatable and preventable blindness, notably DR, age-related macular degeneration, glaucoma, and retinopathy of prematurity. According to the Centers for Disease Control and Prevention, age-related macular degeneration (AMD) is a leading cause of blindness and vision loss among Americans aged 65 and more. According to CDC, the geriatric population in the US is anticipated to nearly double from 48 million in 2015 to 88 million in 2050. Nearly 20 million adults in the US face some form of age-related macular degeneration.
DR is a commonly seen complexity in diabetic patients. According to the International Diabetes Federation (IDF), ~537 million adults (20-79 years of age) were living with diabetes in 2021. The same source also reported that the total number of people living with diabetes is estimated to rise to 643 million by 2030. Further, the study (updated in April 2023) by the American Association for Pediatric Ophthalmology and Strabismus (AAPOS) analyzed that annually in the US, ~3.9 million infants are born with retinopathy of prematurity. Moreover, ~14,000 of these are estimated to be affected by this condition and 90% of those affected have only mild disease, and nearly 1,100- 1,500 develop disease severe enough to require medical treatment. Therefore, such a rise in the prevalence of retinopathy of prematurity, DR, and age-related macular degeneration in the population contributes to the US fundus camera market growth in the US.
Further, fast product approvals in China to treat macular edema further accelerates the adoption of fundus camera in the Asia Pacific region. For records, Bayer announced approval for Eylea to treat patients suffering from visual impairment to treat macular edema. The approval is for the first product indication for Eylea to be approved by the Chinese regulatory body and the injectable eye drug sold by Regeneron. The approval is used to treat conditions like wet age-related macular degeneration, retinal vein occlusion, and diabetic macular edema. The aforementioned factors will accelerate the adoption of fundus camera market during the forecast period 2022-2030.
Market Opportunity
Fundoscopy with Smartphones
The evolution of high-resolution smartphone cameras can revolutionize traditional fundus photography. For example, ophthalmologists are bringing innovations in the field of fundoscopy by exploring the possibility of replacing binocular indirect ophthalmoscopes with a smartphone. Smartphone-aided fundoscopy is a high-tech, low-cost imaging alternative that benefits users through the portability of a device. The smartphone camera comes equipped with light sources. Moreover, the device provides ready access to secure networks for data transmission.
Mobile devices integrated with augmented reality create an entirely new fundoscopy experience. Companies in the fundus camera market, in collaboration with MedTech businesses, are working on app-based fundoscopy to simplify the eye examination process. For example, the Ullman Indirect App allows users to control the functionality of the corresponding smartphone camera. Through its advanced features, the app enables a manual focus of the camera and saving of focal points of the eye, manual control of the camera exposure, regulation of the flashlight intensity, rotation of images and videos for documenting the findings in a correct orientation, and the export of high-quality images without the need for a screenshot.
Type-Based Insights
Based on type, the fundus cameras market is segmented as mydriatic fundus camera, non-mydriatic fundus camera, hybrid fundus camera, and ROP fundus camera. The non-mydriatic fundus camera segment held the largest market share in 2022. The mydriatic fundus camera accounted a significant CAGR for the fundus cameras market. A non-mydriatic fundus camera focuses on the high-definition image capturing of the optic disc, retina, and lens that can be achieved through a low-power microscope of the instrument without increasing the pupil size. Compared to the mydriatic fundus camera, one of the most significant advantages of a non-mydriatic fundus camera is its revolutionary upgrade offering bigger and clearer image capturing without pupil dilation. Also, a non-mydriatic fundus camera is patient-friendly as well as eliminates a 30-minute waiting time for pupil dilation and eye adjustment after blinking, which assists ophthalmologists in improving the efficiency of diagnosis.
CX-1 Hybrid Digital Mydriatic/Non-Mydriatic (MYD/NM) Retinal Camera is Canon's first hybrid camera and a non-mydriatic camera to use Fundus Autofluorescence (FAF) photography. The CX-1 provides five photograph modes-color, red-free, cobalt, fluorescein angiography (FA), and fundus autofluorescence (FAF).
Likewise, a standalone mydriatic fundus camera prototype was successfully developed with a prototype camera capable of operating in a point-and-shoot manner. Also, the mydriatic fundus camera provides automated image focusing and exposure with the image quality of fundus photos comparable to the existing commercial cameras. For example, the adoption of a mydriatic fundus camera is huge for screening patients suffering from diabetic retinopathy and age-related macular degeneration easily identified from fundus images.
In October 2020, Volk Optical announced the launch of "The Volk VistaView," a new portable mydriatic retinal camera for fundus imaging. The newly launched product provides high-resolution, all-glass, double aspheric optics through intuitive digital platforms that capture sharp, wide-field images and manages patient data on the device.
Portability-Based Insights
Based on portability, the global fundus cameras market is bifurcated into handheld and tabletop. The tabletop segment accounted for a larger market share in 2022. The handheld segment is expected to grow at a higher CAGR during 2020-2030. Fundus photography facilitates the detection and screening of various causes of treatable and preventable blindness, notably diabetic retinopathy (DR), age-related macular degeneration, glaucoma, and retinopathy of prematurity. A handheld camera is a smaller, portable imaging device. This tool is battery-operated and does not need a stand or table to operate. Handheld cameras tend to be more affordable than tabletop cameras. The portability and low cost contribute to the high accessibility of retinal imaging devices. Handheld cameras are used in homes, mobile clinics, and health fairs.
Modern handheld fundus cameras combined with autonomous AI systems are well-suited in DR screening without mydriasis because of the high sensitivity of detection and image quality. However, the specificity of these cameras needs to be improved with better modelling of the data. Volk iNview fundus camera by Mentor, Ohio, US, can be connected with an iPhone 6s/6/5s or iPod Touch (Gen 6) through an app. The Volk Pictor Plus is a non-mydriatic fundus camera with posterior (retinal) and anterior imaging modules; the camera uses a proprietary lens, and the application can be downloaded to take fundus images. Handheld cameras are now emerging as a new low-cost tool for DR screening, which can be conveniently used by patients who may not have access to ophthalmological care.
Application-Based Insights
In terms of application, the fundus cameras market is segmented as diabetic retinopathy, age-related macular degeneration, retinal vascular disorders, and others. The diabetic retinopathy segment accounted for the largest fundus cameras market share in 2022. Diabetes mellitus (DM) is considered to be a disease of epidemic proportions. According to the Diabetes Research Institute, 37.3 million people in the US are currently suffering from diabetes.
Diabetic retinopathy (DR) is among the most significant long-term complications of diabetes mellitus and a leading cause of blindness in individuals of aged 20-74 years. As of 2020, the number of adults in the US suffering from diabetic retinopathy was ~8 million; it is expected to reach 16 million by 2050. It can be proliferative (growing) or nonproliferative (not growing), referring to the development of abnormal blood vessels in the retina. Nonproliferative retinopathy is much more common and may not require treatment. When the regular blood vessels cut off in proliferative retinopathy, aberrant blood vessels begin to form. The proliferative form of retinopathy may cause visual loss. The course of retinopathy from nonproliferative to proliferative phases should be monitored with routine eye exams. Fundus photography is crucial in managing and documenting diabetic eye diseases. Traditionally, fundus photography has been performed using film, but recently, digital fundus photography has gained significant traction. Digital images enable easy and immediate review of images, straightforward image magnification, and ability to easily validate the images.
Food and Drug Administration, American Association for Pediatric Ophthalmology and Strabismus, Saudi Food and Drug Authority (SFDA), and American Hospital Association (AHA) are the primary and secondary sources referred to while preparing the report on the fundus camera market.